Home Studieinformatie Studies in voorbereiding

Acute myeloïde leukemie (AML)

NK4AML: Infusion of ex vivo-generated allogeneic natural killer cells in combination with subcutaneous IL-2 in patients with acute myeloid leukemia: a phase I/IIa study

Myelodysplastisch syndroom (MDS)

IMerge 2: A study to evaluate imetelstat (GRN163L) in transfusion-dependent subjects with IPSS low or intermediate-1 risk myelodysplastic syndrome (MDS) that is relapsed/refractory to erythropoiesis-stimulating agent (ESA) treatment

Supportive care

REDDS2: A randomised feasibility n-of-1 trial of weekly-interval red cell transfusion in myelodysplastic syndrome

DUET2: Azole-echinocandin combination therapy for invasive aspergillosis. A randomized pragmatic superiority trial

ReSPECT: A phase 3, multicenter, randomized, double-blind study of the efficacy and safety of rezafungin for injection versus the standard antimicrobial regimen to prevent invasive fungal diseases in adults undergoing allogeneic blood and marrow transplantation


TAP-100: Validation TAP-100 blood collection device

HISTORY: Hypoplasminogenemia: an international retrospective and prospective cohort study

OPTI-CLOT: To WiN: Implementation of pharmacokinetic-guided dosing of DDAVP and VWF-containing concentrates in von Willebrand disease


SCORE: Sickle cell outcome research

Sickle cell screen: Investigating red blood cell deformability of sickle cell patients before and after the start of therapy

Ga terug naar de algemene homepage Studieprotocollen.